Candesartan Cilexetil

CAS 145040-37-5 17 current records 11 historicalSmall Molecule

Who holds supplier records for Candesartan Cilexetil? 17 organisations hold a current record for Candesartan Cilexetil: an active US FDA Type II Drug Master File or a CEP. A further 11 organisations have only historical (inactive) DMF filings. 13 of them hold a valid EU Certificate of Suitability (14 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (8), China (5), Spain (1), Netherlands (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Candesartan Cilexetil: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/candesartan-cilexetil

Reading the evidence

  • 17 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 7 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (17)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Candesartan Cilexetil. Country is the organisation's recorded country, not necessarily the manufacturing site.

India8China5Spain1Netherlands1Slovenia1Country not recorded for 1
Need Candesartan Cilexetil sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (14)

Certificates of Suitability on the EDQM register for Candesartan Cilexetil, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 25 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. ZhuhaiCN
CEP 2023-096 - Rev 02
Candesartan cilexetil, Process 2
Sept 2026—
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2019-303 - Rev 05
Candesartan cilexetil, Process II
May 2026—
JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. YichunCN
CEP 2013-007 - Rev 05
Candesartan cilexetil
Jun 2025—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 2019-297 - Rev 03
Candesartan cilexetil, Process-IV
May 2025—
TAPI NL B.V. AmsterdamNL
CEP 2011-248 - Rev 03
Candesartan cilexetil, Form I
Jan 2025—
ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou CityCN
CEP 2013-256 - Rev 03
Candesartan cilexetil
Sept 2024—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. LinhaiCN
CEP 2011-309 - Rev 05
Candesartan cilexetil, Sieving and non-sieving
Sept 2024Inspected May 2026
Italy
SMILAX LABORATORIES LIMITED HyderabadIN
CEP 2022-171 - Rev 00
Candesartan cilexetil
Mar 2024—
KRKA, d.d., Novo mesto Novo mestoSI
CEP 2016-132 - Rev 01
Candesartan cilexetil
Feb 2024Inspected Jul 2025
Slovenia
CHROMO LABORATORIES INDIA PRIVATE LIMITED PashamylaramIN
R1-CEP 2011-367 - Rev 03
Candesartan cilexetil
Jun 2023—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
R1-CEP 2011-266 - Rev 05
Candesartan cilexetil
May 2023—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
R1-CEP 2014-042 - Rev 01
Candesartan cilexetil
Jan 2023—
ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Sanzao TownCN
R1-CEP 2013-314 - Rev 01
Candesartan cilexetil
Jan 2021—
QUIMICA SINTETICA S.A. Alcala De HenaresES
R1-CEP 2013-228 - Rev 02
Candesartan cilexetil
Jun 2020—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (11)

Organisations whose Type II DMFs for Candesartan Cilexetil are no longer active. These show a past filing, not current supply.

Show all 11 historical records

Overview

Candesartan Cilexetil is a prodrug that is hydrolyzed to candesartan during absorption from the gastrointestinal tract. It is an angiotensin II receptor blocker used to treat hypertension and heart failure.

Chemical identity

IUPAC name
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
Canonical SMILES
CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OC(C)OC(=O)OC6CCCCC6
InChIKey
GHOSNRCGJFBJIB-UHFFFAOYSA-N
Synonyms
Atacand API, atacand, nsc-758697, tcv-116

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Angiotensin 2 Receptor Blocker
Mechanism of action
Angiotensin 2 Receptor Antagonists

Therapeutic areas

CardiovascularHypertension

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Candesartan Cilexetil?

17 organisations hold an active US FDA Type II Drug Master File or a CEP for Candesartan Cilexetil: ULKAR KIMYA SANAYII VE TICARET AS, Zydus Lifesciences Limited (India), Alembic Pharmaceuticals Limited (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India), Macleods Pharmaceuticals Ltd. (India), MATRIX PHARMACORP PRIVATE LTD (India), Zhejiang Huahai Pharmaceutical Co., Ltd. (China) and ZHUHAI RUNDU PHARMACEUTICAL CO LTD (China), and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Candesartan Cilexetil Drug Master Files are active?

ULKAR KIMYA SANAYII VE TICARET AS (DMF 25216, 26996), Zydus Lifesciences Limited (DMF 23693, 18828), Alembic Pharmaceuticals Limited (DMF 21507, 30240), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 25797), Macleods Pharmaceuticals Ltd. (DMF 24810), MATRIX PHARMACORP PRIVATE LTD (DMF 20400), Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 25455) and ZHUHAI RUNDU PHARMACEUTICAL CO LTD (DMF 37468) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Candesartan Cilexetil records mean?

11 organisations have only inactive Type II DMFs for Candesartan Cilexetil. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Candesartan Cilexetil have a European Certificate of Suitability?

Yes. 13 organisations hold a valid CEP for Candesartan Cilexetil on the EDQM register, including ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Zhuhai (CN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. Yichun (CN), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), TAPI NL B.V. Amsterdam (NL) and ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City (CN) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Candesartan Cilexetil supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Candesartan Cilexetil?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.